SBPWG:Meetings/Nov 15 2011: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
(→Audio) |
||
(5 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
'''November 15th 6:30-8:30pm @ UCSF Mission Bay (room TBA)''' | '''November 15th 6:30-8:30pm @ UCSF Mission Bay (room TBA)''' | ||
* [http://bioeng.berkeley.edu/cv/canderson.php '''Chris Anderson'''], assistant professor of Bioengineering at UC Berkeley and SynBERC PI, | * [http://bioeng.berkeley.edu/cv/canderson.php '''Chris Anderson'''], assistant professor of Bioengineering at UC Berkeley and SynBERC PI, joined the working group to pitch, discuss and get feedback on several prospective biosafety-related projects addressing challenges in biological design, education and management. | ||
===Attendees=== | ===Attendees=== | ||
Line 24: | Line 23: | ||
===Slides=== | ===Slides=== | ||
See slides [[Media:AndersonBiosafety.ppt | here]] | |||
===Audio=== | ===Audio=== | ||
Download audio file [[Media:AndersonSBPWG.wav | here]] | |||
===Pictures=== | ===Pictures=== | ||
[[Image:AndersonSBPWGpic.JPG]] | |||
===Notes=== | |||
Notes transcribed by Ellick Chan | |||
Please see the timestamps below to jump to a particular section. | |||
16:00 | |||
*Start | |||
*Working Group Origins at Synberc Spring retreat. Issues covered in practices. Translation, safety, security. | |||
*Recombinant DNA, film | |||
*Discovery Days science festival | |||
*Biotech bootcamp | |||
18:30 | |||
* Megan intro to Safety issues | |||
19:00 | |||
* Chris: topics covered | |||
**1) Containment | |||
**2) Training | |||
**3) Assessing risk | |||
Don't want people making smallpox - not directly issue of synthetic bio. No one is working in that area. | |||
Politics of biosafety - economics. Models for risk. Responding to risks. No financial collapse. Actively mitigate risk. | |||
23:00 | |||
* Making an effective containment strategy - Auxotrophy | |||
* Self-kill device in cell: problems | |||
*containment of org | |||
**codon swapping | |||
**containment of DNA | |||
**Dapd auxotropes | |||
**unnatural amino acid dependence | |||
**self destruct device | |||
**synthetic auxotrophes | |||
*What's the edit distance to something dangerous? | |||
*What is dangerous? | |||
*Lack of a theory to assess danger | |||
28:00 | |||
*modifications cannot escape by complementation | |||
*cannot revert through natural mutation | |||
*sufficiently inexpensive to use in a bioreactor | |||
*no adverse impact on viability of the cell | |||
*be extensible to industrially relevant organisms | |||
31:00 | |||
*pick a gene that can't be knocked out or complemented | |||
*small molecule dependency | |||
*allele exchange of new copy with mutant copy | |||
*300 essential genes in ecoli | |||
*tour based selection system | |||
36:00 | |||
*another paper based on a similar technique | |||
* politics | |||
* design to contain nature. if it breaks out, it may be our fault. | |||
* what's the bar for regulation? | |||
* assay to prove safety/effectiveness | |||
* not our role to set our own bar - someone else should set it | |||
39:00 | |||
* ques: academic research on rates? chris - industry will say so | |||
41:00 | |||
*training | |||
*NSF needs curriculum for SynBERC | |||
*Berkeley has classes, but most other institutions don't | |||
*Ethics class? | |||
*Online training module for biosafety | |||
*heart of the problem - no theory on safety | |||
*BUA - Biological Use Authorization -> NIH guidelines | |||
*explosion of genes - no one knows all the risks of them off the top of their head | |||
49:00 | |||
*risk assessment | |||
*6 categories | |||
**virulence | |||
**environmental stability | |||
**communicability | |||
**quantity | |||
**vaccine | |||
**allergenicity | |||
**potential for nefarious use | |||
* sign off by committee if necessary | |||
* never seen them say no. may give you recommendations | |||
* rarely/never re-review in the case of new identified risk | |||
54:00 | |||
*quizzes are basically a checklist of thoughts that the student should consider | |||
* megan - does such a flowchart exist? | |||
* biosafety guys aren't that scared of synth bio compared to other risks | |||
* subjective questions | |||
* risk should be considered from factors other than the originating organism | |||
64:00 | |||
* assessment | |||
* risk based on features | |||
* if it can be programmed, there should be enough formalization to do so | |||
* formalism simplifies things | |||
* evaluation of risk depends on biologist's perspective | |||
* first attempt | |||
70:00 | |||
* minimize risk - example in radiation safety | |||
* payload delivery | |||
* risk group is max risk at any stage | |||
* transposon not caught | |||
* chassis can be dangerous | |||
* device can be more dangerous than sum of its components | |||
* substance could be dangerous in a different context | |||
80:00 | |||
* unintentional promoter can express gene in unknown ways | |||
* accidental recombination | |||
* act ontology | |||
** feature, family, device | |||
*autorepression device | |||
88:00 | |||
* verification and synthesis | |||
* families - by hand | |||
* features - partially automated | |||
* main issue: how to populate list | |||
* all knowledge in literature, but not enough manpower to pursue | |||
* inference of devices resulting from modifications | |||
92:00 | |||
*map dangerous functionality to devices | |||
* scenarios of things that are dangerous, but not obviously dangerous | |||
* engineered peanut allergy on salmonella | |||
* curate high level families for danger | |||
* what's the difference between a strain (cell+genome+plasmid mods) and a device(modification, composition of devices can create a strain)? | |||
* strains as combination of devices. complex network. | |||
* look at interactions between added features + original genome | |||
100:00 | |||
* Peanut peptide combining with transporter | |||
* Megan: is there a theory on what constitutes danger on a given agent. Weaponization of anthrax - what's the special knowledge needed to make it harmful | |||
* 2001 list doesn't consider starting path and possible paths to dangerous agents | |||
* megan: can we classify existing dangerous agents and process of creation? | |||
* megan: how do we hedge our bets in making sure we're doing good work in this area? From DARPA's perspective? Safe chassis development vs automated monitoring vs surveillance vs forensics | |||
* megan: partnerships/funding | |||
* nsf cares about training | |||
* containment | |||
* megan: orthogonal genome vs selective growth environment | |||
112:00 | |||
* orthogonal genomes very academic, but probably not industrializable - whole platform required to make this work | |||
* what are axes of risk? | |||
* danger from synergistic reaction adding to risk | |||
* expert system, review committee | |||
120:00 | |||
* megan: is there a politically-safe way to get a group to look at these issues? what would pr think? | |||
* most of these are obvious | |||
* is there an arms race for risk assessment schemes? | |||
* ACT theory is open knowledge | |||
* value will be in list of devices to query for risk | |||
* this can be used to find dangerous devices… | |||
Wrap-up: | |||
* Naming devices and rubric is interesting | |||
* Doing exercise around context of training module | |||
* Siebel foundation event coming up | |||
* New ways to fund biosafety | |||
* OSTP request for info - december 6th | |||
* Leaders in practice, 1 week bootcamp in summer - in DC |
Latest revision as of 23:51, 17 November 2011
Meeting Notes: November 15 2011
November 15th 6:30-8:30pm @ UCSF Mission Bay (room TBA)
- Chris Anderson, assistant professor of Bioengineering at UC Berkeley and SynBERC PI, joined the working group to pitch, discuss and get feedback on several prospective biosafety-related projects addressing challenges in biological design, education and management.
Attendees
- Megan Palmer (Stanford)
- Ryan Ritterson (UCSF)
- Jay Vowles (Stanford)
- Connie Eaves (UCSF)
- Veronica Zepeda (UCSF)
- Andy Chang (Stanford)
- Josh Wolf (UCSF)
- Nathan Hillson (JBEI)
- Kevin Costa (SynBERC)
- Chris Anderson (Berkeley)
- Derek Greenfield (LS9)
- Mike Fero (Teselagen)
- Eduardo Abeliuk (Teselagen)
- Ellick Chan (Stanford)
Slides
See slides here
Audio
Download audio file here
Pictures
Notes
Notes transcribed by Ellick Chan
Please see the timestamps below to jump to a particular section.
16:00
- Start
- Working Group Origins at Synberc Spring retreat. Issues covered in practices. Translation, safety, security.
- Recombinant DNA, film
- Discovery Days science festival
- Biotech bootcamp
18:30
- Megan intro to Safety issues
19:00
- Chris: topics covered
- 1) Containment
- 2) Training
- 3) Assessing risk
Don't want people making smallpox - not directly issue of synthetic bio. No one is working in that area.
Politics of biosafety - economics. Models for risk. Responding to risks. No financial collapse. Actively mitigate risk.
23:00
- Making an effective containment strategy - Auxotrophy
- Self-kill device in cell: problems
- containment of org
- codon swapping
- containment of DNA
- Dapd auxotropes
- unnatural amino acid dependence
- self destruct device
- synthetic auxotrophes
- What's the edit distance to something dangerous?
- What is dangerous?
- Lack of a theory to assess danger
28:00
- modifications cannot escape by complementation
- cannot revert through natural mutation
- sufficiently inexpensive to use in a bioreactor
- no adverse impact on viability of the cell
- be extensible to industrially relevant organisms
31:00
- pick a gene that can't be knocked out or complemented
- small molecule dependency
- allele exchange of new copy with mutant copy
- 300 essential genes in ecoli
- tour based selection system
36:00
- another paper based on a similar technique
- politics
- design to contain nature. if it breaks out, it may be our fault.
- what's the bar for regulation?
- assay to prove safety/effectiveness
- not our role to set our own bar - someone else should set it
39:00
- ques: academic research on rates? chris - industry will say so
41:00
- training
- NSF needs curriculum for SynBERC
- Berkeley has classes, but most other institutions don't
- Ethics class?
- Online training module for biosafety
- heart of the problem - no theory on safety
- BUA - Biological Use Authorization -> NIH guidelines
- explosion of genes - no one knows all the risks of them off the top of their head
49:00
- risk assessment
- 6 categories
- virulence
- environmental stability
- communicability
- quantity
- vaccine
- allergenicity
- potential for nefarious use
- sign off by committee if necessary
- never seen them say no. may give you recommendations
- rarely/never re-review in the case of new identified risk
54:00
- quizzes are basically a checklist of thoughts that the student should consider
- megan - does such a flowchart exist?
- biosafety guys aren't that scared of synth bio compared to other risks
- subjective questions
- risk should be considered from factors other than the originating organism
64:00
- assessment
- risk based on features
- if it can be programmed, there should be enough formalization to do so
- formalism simplifies things
- evaluation of risk depends on biologist's perspective
- first attempt
70:00
- minimize risk - example in radiation safety
- payload delivery
- risk group is max risk at any stage
- transposon not caught
- chassis can be dangerous
- device can be more dangerous than sum of its components
- substance could be dangerous in a different context
80:00
- unintentional promoter can express gene in unknown ways
- accidental recombination
- act ontology
- feature, family, device
- autorepression device
88:00
- verification and synthesis
- families - by hand
- features - partially automated
- main issue: how to populate list
- all knowledge in literature, but not enough manpower to pursue
- inference of devices resulting from modifications
92:00
- map dangerous functionality to devices
- scenarios of things that are dangerous, but not obviously dangerous
- engineered peanut allergy on salmonella
- curate high level families for danger
- what's the difference between a strain (cell+genome+plasmid mods) and a device(modification, composition of devices can create a strain)?
- strains as combination of devices. complex network.
- look at interactions between added features + original genome
100:00
- Peanut peptide combining with transporter
- Megan: is there a theory on what constitutes danger on a given agent. Weaponization of anthrax - what's the special knowledge needed to make it harmful
- 2001 list doesn't consider starting path and possible paths to dangerous agents
- megan: can we classify existing dangerous agents and process of creation?
- megan: how do we hedge our bets in making sure we're doing good work in this area? From DARPA's perspective? Safe chassis development vs automated monitoring vs surveillance vs forensics
- megan: partnerships/funding
- nsf cares about training
- containment
- megan: orthogonal genome vs selective growth environment
112:00
- orthogonal genomes very academic, but probably not industrializable - whole platform required to make this work
- what are axes of risk?
- danger from synergistic reaction adding to risk
- expert system, review committee
120:00
- megan: is there a politically-safe way to get a group to look at these issues? what would pr think?
- most of these are obvious
- is there an arms race for risk assessment schemes?
- ACT theory is open knowledge
- value will be in list of devices to query for risk
- this can be used to find dangerous devices…
Wrap-up:
- Naming devices and rubric is interesting
- Doing exercise around context of training module
- Siebel foundation event coming up
- New ways to fund biosafety
- OSTP request for info - december 6th
- Leaders in practice, 1 week bootcamp in summer - in DC